Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Colletti

Showing results (121-130 of 230) with videos related to

Pageof 23
Sort By:
Clinical Nuclear Medicine|January 3, 2018
Stress Lymphoscintigraphy for Early Detection and Management of Secondary Limb LymphedemaGirolamo Tartaglione, Giuseppe Visconti, Roberto Bartoletti, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2012
Measuring bone mineral density with fat-water MRI: comparison with computed tomographyKai-Yu Ho, Houchun H Hu, Joyce H Keyak, et al.
American Journal of Physical Medicine & Rehabilitation|July 25, 2009
Multifidus morphology in persons scheduled for single-level lumbar microdiscectomy: qualitative and quantitative assessment with anatomical correlatesKornelia Kulig, Alison R Scheid, Robin Beauregard, et al.
Clinical Nuclear Medicine|July 16, 2019
In Vivo Microbial Targeting of 99mTc-Labeled Human β-Defensin-3 in a Rat Model of InfectionGiulia Anna Follacchio, Alessandro Pala, Sergio Scaccianoce, et al.
Clinical Nuclear Medicine|July 17, 2013
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer diseaseMarino Cimitan, Marina Hodolič, Anna Margherita Maffione, et al.
Clinical Nuclear Medicine|March 6, 2015
Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive casesSotirios Chondrogiannis, Maria Cristina Marzola, Gaia Grassetto, et al.
Clinical Nuclear Medicine|July 8, 2014
Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negativeAnna Margherita Maffione, Laura Camilla Lisato, Annalisa Rasi, et al.
Clinical Nuclear Medicine|November 13, 2018
Sentinel Lymph Node Biopsy in Small Papillary Thyroid Cancer: A Meta-analysisLudovico M Garau, Domenico Rubello, Riccardo Morganti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2021
EANM guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)Roberto C Delgado Bolton, Nicolas Aide, Patrick M Colletti, et al.
Clinical Nuclear Medicine|June 12, 2013
Evolving role of SPECT/CT in neuroendocrine tumors management: staging, treatment response, and follow-upChiara Fuccio, Elena Giulia Spinapolice, Sotirios Chondrogiannis, et al.
Pageof 23

Showing results (121-130 of 230) with videos related to

Sort By:
Pageof 23
Clinical Nuclear Medicine|January 3, 2018
Stress Lymphoscintigraphy for Early Detection and Management of Secondary Limb LymphedemaGirolamo Tartaglione, Giuseppe Visconti, Roberto Bartoletti, et al.
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2012
Measuring bone mineral density with fat-water MRI: comparison with computed tomographyKai-Yu Ho, Houchun H Hu, Joyce H Keyak, et al.
American Journal of Physical Medicine & Rehabilitation|July 25, 2009
Multifidus morphology in persons scheduled for single-level lumbar microdiscectomy: qualitative and quantitative assessment with anatomical correlatesKornelia Kulig, Alison R Scheid, Robin Beauregard, et al.
Clinical Nuclear Medicine|July 16, 2019
In Vivo Microbial Targeting of 99mTc-Labeled Human β-Defensin-3 in a Rat Model of InfectionGiulia Anna Follacchio, Alessandro Pala, Sergio Scaccianoce, et al.
Clinical Nuclear Medicine|July 17, 2013
Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer diseaseMarino Cimitan, Marina Hodolič, Anna Margherita Maffione, et al.
Clinical Nuclear Medicine|March 6, 2015
Optimized protocol for (18)F-choline PET/CT in patients with biochemically relapsed prostate cancer: experiences on 250 consecutive casesSotirios Chondrogiannis, Maria Cristina Marzola, Gaia Grassetto, et al.
Clinical Nuclear Medicine|July 8, 2014
Lobular breast carcinoma: a case of rare possible 18F-FDG PET/CT and bone scan false negativeAnna Margherita Maffione, Laura Camilla Lisato, Annalisa Rasi, et al.
Clinical Nuclear Medicine|November 13, 2018
Sentinel Lymph Node Biopsy in Small Papillary Thyroid Cancer: A Meta-analysisLudovico M Garau, Domenico Rubello, Riccardo Morganti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2021
EANM guideline on the role of 2-[<sup>18</sup>F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)Roberto C Delgado Bolton, Nicolas Aide, Patrick M Colletti, et al.
Clinical Nuclear Medicine|June 12, 2013
Evolving role of SPECT/CT in neuroendocrine tumors management: staging, treatment response, and follow-upChiara Fuccio, Elena Giulia Spinapolice, Sotirios Chondrogiannis, et al.
Pageof 23